Clinical and preclinical studies reported increased complement proteins in the brain and CSF in amyotrophic lateral sclerosis, stroke, epilepsy, traumatic brain injury, multiple sclerosis, and Alzheimer’s disease (reviewed in refs. 8,12). This evidence concerns the gene VTN and Stroke.